Episodes

Brookline's Patrick Sturgeon on when a SPAC beats an IPO or direct listing, including phased capital raising through PIPEs and easier earnout structures.

Odyssey Trust's Caitlyn Van Valin on how the firm handled over half of new SPAC listings in 2024, using dedicated SPAC pods for redemptions, disbursements, and closings.

Adeel Rouf makes the case for biotech and fintech as overlooked SPAC sectors, with many quality biotech companies still deeply discounted since 2021.

Louis Camhi on how a 2014 call about a SPAC deal led him from covering fintech at hedge funds to becoming a dedicated SPAC investor and fund manager.

Adeel Rouf shares candid lessons from 10+ SPAC deals, from rushing companies public before they were ready to underestimating the pressure of quarterly reporting.

Louis Camhi on the biggest SPAC misperceptions, including why a pre-deal SPAC behaves like a convertible bond while a de-SPAC trades like a regular equity.

Lockton's Machua Millett on his path from securities lawyer to D&O expert, and how his legal background helps clients write stronger policy language.

Adeel Rouf on what makes a SPAC target public-ready: audited financials, seasoned investors, prior funding rounds, and a management team built for the public spotlight.

A SPAC Holdings CEO Claudius Tsang on raising US capital as an Asian sponsor, and why educating US investors on emerging-market track records is key.

Claudius Tsang, one of Asia's most active SPAC sponsors, on moving from private equity to SPACs and launching seven Nasdaq-listed vehicles since 2021.

CohnReznick's Mohammad Hasham on why SPAC teams should engage experienced advisors early, and how chemistry between auditors and counsel prevents costly audit problems.

Cayman attorney Alexandra Low on de-SPAC structures, from TopCo listings and cross-border mergers to deregistration strategies and post-merger tax planning.

Dr. Daniele D'Alvia on how law and corporate governance, from independent directors to robust disclosure, give SPACs the structural integrity to succeed.

Voyager CEO Adeel Rouf on what makes SPACs unique: one deal at a time, blending private investing with the move to public markets.

Voyager CEO Adeel Rouf on his path from investment banking to sponsoring 10+ SPACs, raising over $2B in IPOs and executing more than $5B in de-SPAC deals.

Brookline's Patrick Sturgeon on why private companies go public: liquidity for shareholders, new investors, more capital, and greater visibility in the markets.

Brookline's Patrick Sturgeon on his path through investment banking and serving as CFO of three SPACs that completed acquisitions.

Centri's Derek Kearns on what happens behind the scenes of a de-SPAC, from early capital markets readiness to pro forma financials and the SEC comment process.

L Investments CIO Candice Beaumont on how she evaluates SPAC sponsors: proven track record, experienced operators, and the right legal and service teams.

Brookline's Dimitre Genov on the sectors shaping SPAC demand, from AI, nuclear, and quantum to steady industrials, spinoffs, and international companies.

Brookline's Dimitre Genov on 25 years across Lazard, JP Morgan, Magnetar, and Balyasny, and how he now helps SPAC sponsors find quality targets.

Chaz Churchwell on a data-driven way to size D&O coverage, using litigation research, peer benchmarks, market cap, and industry segment.

ICAN founder Nick Morgan on how the SEC approaches SPAC enforcement, and what Commissioner Hester Peirce's dissents reveal about the Commission's view.

Former SEC senior trial counsel Nick Morgan on founding ICAN, a pro bono organization defending people in SEC investigations and litigation at no cost.